FORWARD FEATURES CALENDAR

Funds

Future Fund: Breakthrough now open for investor applications

Future Fund: Breakthrough, announced by the Chancellor of the Exchequer at Budget 2021, is now open for applications. This UK-wide programme will deliver GBP375 million of government funding via British Patient Capital, a commercial subsidiary of the British Business Bank. Due to high research and development costs, breakthrough technology companies

GCA Altium advises Aspria on EUR53m investment from Fortress Investment Group

GCA Altium has advised Aspria, a London headquartered, founder-led operator of super premium health focused clubs and hotels across Europe, on a EUR53 million investment from funds managed by affiliates of Fortress Investment Group (Fortress). Aspria, founded in 2000 and headquartered in London, UK, is a collection of Europe’s finest

CV VC extends operations to UAE and Africa

CV VC, a Swiss blockchain venture capitalist and incubator has not only extended its VC operations internationally to UAE and Africa but now offers fully compliant, bankable and transferable participation in an underlying portfolio of blockchain assets, delivering a balancing opportunity, high return potential and diversification.  The CV VC investment

Fuse Venture Partners makes strategic Principal appointment in consumer tech team

Fuse Venture Partners (Fuse), a European internet growth venture investor, has appointed Dipam Patel as a Principal, bringing over 10 years’ technology and investing experience to the firm. Patel will work with the eight-person London-based European-focused team led by Managing Partner Spyro Korsanos as it looks to expand the firm’s

XPhyto to acquire 3a-diagnostics

XPhyto Therapeutics Corp is to acquire 3a-diagnostics, Frickenhausen, Germany (3a), the company’s exclusive diagnostics development partner.  Pursuant to the definitive agreement, XPhyto will acquire all of the outstanding shares of 3a for EUR400,000, to be paid immediately, and EUR3.5 million, to be paid on closing, planned for on or around

Panakés holds first closing of new ‘Purple’ life sciences fund at EUR150m

Panakès Partners, an leading Italian venture capital firm focused on the Life Sciences sector, has held the first closing of its EUR150 million (USD180 million) Purple Fund, the firm’s second fund. Panakès’ Purple Fund is currently the largest venture capital fund actively investing in Italian companies and the most significant

Ntropy raises USD3.2m in seed round

Ntropy, a company aiming to remove the data barriers to understanding financial transactions, has closed a USD3.2 million seed round led by QED Investors, who has previously invested in fintech unicorns Nubank, Klarna, and Current.  Ntropy’s API enables businesses to convert raw data into contextualised and structured information understood by

Keensight Capital to exit ASTI

Keensight Capital, a private equity manager dedicated to pan-European Growth Buyout investments, is to sell, alongside the founder, its stake in ASTI, a global autonomous mobile robotics (AMR) manufacturer, to ABB. Founded in 1982, ASTI supports one of Europe’s largest installed fleets of Autonomous Mobile Robots (AMRs) and has a

“ESG screen” grows in importance for private equity investments

The majority (62 per cent) of GPs have declined to invest in a company due to ESG or ethical considerations in 2021, according to Investec’s annual GP Trends survey. Last year, this figure stood at 55 per cent, showing the continued and growing importance of ESG to GPs. Investec’s research,

Events

12 November, 2026 – 5:00 pm

Directory Listings